Laird Norton Wetherby Trust Company’s Eli Lilly LLY Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.1M	Sell	39,217 -1,908	-5%	-$1.93M	0.79%	23
2025 Q4	$44.2M	Buy	+41,125	New	+$39.3M	0.92%	20
2024 Q2	–	Sell	-11,458	Closed	-$8.91M	–	79
2024 Q1	$8.91M	Hold	11,458	–	–	1.21%	12
2023 Q4	$6.68M	Sell	11,458 -4,515	-28%	-$2.64M	0.79%	21
2023 Q3	$8.58M	Hold	15,973	–	–	1.1%	14
2023 Q2	$7.49M	Sell	15,973 -798	-5%	-$335K	0.88%	16
2023 Q1	$5.76M	Hold	16,771	–	–	0.72%	18
2022 Q4	$6.14M	Sell	16,771 -2,155	-11%	-$764K	0.87%	15
2022 Q3	$6.12M	Sell	18,926 -643	-3%	-$204K	1.39%	12
2022 Q2	$6.34M	Sell	19,569 -93	-0.5%	-$27.9K	0.8%	16
2022 Q1	$5.63M	Sell	19,662 -183	-0.9%	-$47.1K	0.51%	22
2021 Q4	$5.48M	Sell	19,845 -29	-0.1%	-$7.35K	0.51%	20
2021 Q3	$4.59M	Buy	19,874 +4,110	+26%	+$1.01M	0.47%	22
2021 Q2	$3.62M	Sell	15,764 -82	-0.5%	-$16.5K	0.38%	28
2021 Q1	$2.94M	Buy	15,846 +823	+5%	+$161K	0.32%	30
2020 Q4	$2.54M	Buy	+15,023	New	+$2.24M	0.28%	31

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Laird Norton Wetherby Trust Company's LLY Position: Q1 2026 in Review

Laird Norton Wetherby Trust Company reduced its Eli Lilly (LLY) stake by 4.6% in Q1 2026, selling an estimated $1.93M and leaving 39,217 shares worth $36.1M. The position accounts for 0.79% of the portfolio, ranked #23.

Laird Norton Wetherby Trust Company first reported a position in LLY in Q4 2020 and has held it in 16 quarters since. The position peaked at $44.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Laird Norton Wetherby Trust Company held 39,217 shares of Eli Lilly worth $36.1M as of Q1 2026.
Laird Norton Wetherby Trust Company sold 1,908 Eli Lilly shares in Q1 2026, an estimated $1.93M.
Eli Lilly made up 0.79% of Laird Norton Wetherby Trust Company's portfolio in Q1 2026, its #23 holding.
Laird Norton Wetherby Trust Company first reported a position in Eli Lilly in Q4 2020 and has held it in 16 quarters since.
Laird Norton Wetherby Trust Company's Eli Lilly position peaked at $44.2M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2026, filed 15 May 2026.